Biliary Tract Cancer Completed Phase 2 Trials for Capecitabine (DB01101)

Also known as: Biliary tract cancer / Cancers, Biliary Tract / Malignant neoplasm of biliary tract, unspecified / Malignant tumor of biliary tract / Malignant neoplasm of biliary tract, part unspecified

IndicationStatusPhase
DBCOND0030617 (Biliary Tract Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00142480Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Patients With Biliary Tract and Gallbladder CancerTreatment
NCT01530503Second Line Therapy in Advanced Biliary Tract CancerTreatment
NCT01572324Study of Hepatic Arterial Infusion to Treat Biliary Tract CarcinomasTreatment